Based on recent data, Summit Therapeutics Inc. (SMMT) shows an Average True Range (ATR) of 0.79 and an Enterprise Value of 2.55B. Its average trading volume over the past 3 months is 2.76M, indicating liquidity. These fundamental metrics provide insight into SMMT's underlying financial health and market activity.
| ATR | 0.79 |
| Enterprise Value | 2.55B |
| Avg Vol (3 Months) | 2.76M |
| Avg Vol (10 Days) | 2.7M |
Summit Therapeutics Inc. (SMMT) technical indicators as of January 11, 2026: the SMA 20 is 9.72%, SMA 50 at 9.86%, and SMA 200 at -9.75%. The RSI 14 value is 64.81, suggesting its current momentum. These technical analysis signals help assess SMMT's price trends and potential future movements.
| SMA 20 | 9.72% |
| SMA 50 | 9.86% |
| SMA 200 | -9.75% |
| RSI 14 | 64.81 |
Summit Therapeutics Inc. (SMMT) stock performance overview as of January 11, 2026: The 52-week high is $36.91 (currently -46.68% below), and the 52-week low is $15.55 (currently 26.56% above). Over the past year, SMMT's performance is 2.62%, compared to the S&P 500's 12.34% change.
| 52-Week High | 36.91 |
| 52-Week High Chg | -46.68% |
| 52-Week Low | 15.55 |
| 52-Week Low Chg | +26.56% |
| S&P 500 52-Week Chg | 12.34% |
According to market data, Summit Therapeutics Inc. (SMMT) stock's recent performance metrics show that over the last month, SMMT is 2.84%, with a Year-to-Date (YTD) performance of 7.66%. Over the past year, the stock has seen a 2.62% change. These figures summarize SMMT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 20.2 | 20.2 | 25.49 | 30.98 | 36.91 | 20.2 |
| Low | 17.29 | 16.81 | 15.62 | 15.62 | 15.55 | 17.29 |
| Performance | +7.66% | +2.84% | -15.52% | -23.89% | +2.62% | +7.66% |
According to current financial data, SMMT stock's P/E (TTM) ratio is -15.87, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for SMMT, including P/S (N/A), P/B (76.10), and P/FCF (-53.84), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | SMMT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -15.87 | -1.24 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 465.9 | 5.98 |
| P/B (TTM) | 76.1 | 0.19 | -335.2 | 6.24 |
| P/FCF (TTM) | -53.84 | -8.98 | -394.53 | 36.55 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep